Perceptive Advisors LLC Protara Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.8 - $5.33 $261,729 - $498,221	-93,475 Reduced 24.37%	290,051 $850,000
Q1 2022 May 16, 2022	SELL	$4.19 - $6.9 $159,701 - $262,993	-38,115 Reduced 9.04%	383,526 $1.96 Million
Q2 2021 Aug 16, 2021	SELL	$8.68 - $16.99 $8 - $16	-1 Reduced -0.0%	421,641 $4.11 Million
Q1 2021 May 17, 2021	SELL	$13.75 - $23.86 $2.57 Million - $4.46 Million	-186,902 Reduced 30.71%	421,642 $6.64 Million
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $10.2 Million - $19.4 Million	608,544 New	608,544 $10.2 Million

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $25.8M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.